(Q39938924)

15 September 2017

1 reference

title

Radioactive iodine therapy for thyrotoxicosis (English)

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

radioactive iodine therapy

10 February 2023

main subject

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

10 February 2023

author name string

W. R. Greig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4594095

10 February 2023

language of work or name

English

0 references

publication date

1 October 1973

1 reference

full work available at URL

15 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fbjs.1800601003

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

http://academic.oup.com/bjs/article-pdf/60/10/758/37079046/bjs1800601003.pdf

10 February 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

British Journal of Surgery

10 February 2023

published in

1 reference

15 September 2017

volume

60

1 reference

15 September 2017

issue

10

1 reference

15 September 2017

page(s)

758-765

1 reference

Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs

15 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Complications of radioiodine treatment of hyperthyroidism

10 February 2023

2

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Incidence of hypothyroidism and recurrences following I-131 treatment of hyperthyroidism

10 February 2023

3

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Treatment of thyrotoxicosis with 131 I; a review of 500 cases.

10 February 2023

5

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Estimates of gonad and genetically significant dose to the United States population from diagnostic roentgenology

10 February 2023

8

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Radioiodine therapy to out-patients—the radiation hazard

10 February 2023

9

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

The treatment of hyperthyroidism with radioactive iodine

10 February 2023

11

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

The use of radioactive iodine in the diagnosis and treatment of hyperthyroidism: ten years' experience

10 February 2023

12

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Effect of pretreatment with methylthiouracil on results of I-131 therapy.

10 February 2023

13

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Hypoparathyroidism following 131-I therapy for hyperthyroidism

10 February 2023

16

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Plasma-calcitonin in disorders of thyroid function.

10 February 2023

17

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Osteoporosis and fractures following thyrotoxicosis

10 February 2023

18

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Blood radiation dose after 131-I therapy of thyrotoxicosis. Calculations with reference to leukaemia

10 February 2023

19

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Radiation, Thyroid Cells and131I Therapy—A Hypothesis

10 February 2023

21

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

EFFECT OF TREATMENT OF THYROTOXICOSIS ON EXOPHTHALMOS

10 February 2023

22

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Plasma-calcitonin in man.

10 February 2023

23

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Propranolol and iodine-131 in the management of thyrotoxicosis

10 February 2023

24

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Comparison of high and low dosage levels of 131-I in the treatment of thyrotoxicosis

10 February 2023

25

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine.

10 February 2023

27

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Long-term outcome of hyperthyroidism treated with antithyroid drugs

10 February 2023

28

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Radiation risk: a scientific problem?

10 February 2023

29

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

The prognostic significance of thyroid antibodies in the management of thyrotoxicosis

10 February 2023

31

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Studies on the pathogenesis of the ophthalmopathy of Graves' disease

10 February 2023

34

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Thyroid Carcinoma Following Iodine-131 Therapy. Report of a Case and Review of the Literature

10 February 2023

36

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

RADIOIODINE THERAPY IN THYROTOXICOSIS; A REVIEW OF 908 CASES.

10 February 2023

37

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Simplified radioactive iodine therapy

10 February 2023

38

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Results of treatment of thyrotoxicosis after postoperative relapse.

10 February 2023

39

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Long-term Follow-up of Surgically Treated Thyrotoxic Patients

10 February 2023

40

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

The long-acting thyroid stimulator

10 February 2023

42

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Leukaemia following radioiodine treatment of thyrotoxicosis.

10 February 2023

44

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study

10 February 2023

46

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

CHILDHOOD THYROTOXICOSIS: A LONG-TERM PERSPECTIVE.

10 February 2023

47

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Clinical trial of different doses of 131-I in treatment of thyrotoxicosis

10 February 2023

50

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Lymphocyte chromosomes in untreated and 131-I-treated thyrotoxic patients

10 February 2023

51

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS)

10 February 2023

54

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Therapeutic effects from repeated diagnostic doses of I131 in adult and juvenile hyperthyroidism

10 February 2023

56

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

Evidence for Thyrocalcitonin in Man

10 February 2023

57

1 reference

https://api.crossref.org/works/10.1002/BJS.1800601003

10 February 2023

Identifiers

1 reference

15 September 2017

1 reference